{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:37:52Z","timestamp":1707525472975},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,5]]},"DOI":"10.7759\/cureus.50007","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T06:21:44Z","timestamp":1701843704000},"source":"Crossref","is-referenced-by-count":0,"title":["Leprosy in a Patient With Lymphoma: A Challenge in the Twenty-First Century"],"prefix":"10.7759","author":[{"given":"Eul\u00e1lia","family":"Antunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas M","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Cubal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sueila","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Tenreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421504112","article-title":"Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis","volume":"112","author":"Singh P","year":"2015","unstructured":"Singh P, Benjak A, Schuenemann VJ, et al.. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis. Proc Natl Acad Sci U S A. 2015, 112:4459-64. 10.1073\/pnas.1421504112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8652062","article-title":"Leprosy: a review of epidemiology, clinical diagnosis, and management","volume":"2022","author":"Chen KH","year":"2022","unstructured":"Chen KH, Lin CY, Su SB, Chen KT. Leprosy: a review of epidemiology, clinical diagnosis, and management. J Trop Med. 2022, 2022:8652062. 10.1155\/2022\/8652062","journal-title":"J Trop Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.29021\/spdv.77.4.1116","article-title":"Leprosy: from antiquity to our times","volume":"77","author":"M\u00e1quina A","year":"2020","unstructured":"M\u00e1quina A, Catarino A, Silva L, Catorze G, Ferreira L, Viana I. Leprosy: from antiquity to our times. J Port Soc Dermatol Venereol. 2020, 77:323-38. 10.29021\/spdv.77.4.1116","journal-title":"J Port Soc Dermatol Venereol"},{"key":"ref4","article-title":"Guidelines for the Diagnosis, Treatment and Prevention of Leprosy","author":"World Health Organization","year":"2018","unstructured":"World Health Organization, Regional Office for South-East Asia. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. World Health Organization, Regional Office for South-East Asia, New Delhi; 2018."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008276","article-title":"Reservoirs and transmission routes of leprosy; a systematic review","volume":"14","author":"Ploemacher T","year":"2020","unstructured":"Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T. Reservoirs and transmission routes of leprosy; a systematic review. PLoS Negl Trop Dis. 2020, 14:e0008276. 10.1371\/journal.pntd.0008276","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010536","article-title":"Probable zoonotic leprosy in the southern United States","volume":"364","author":"Truman RW","year":"2011","unstructured":"Truman RW, Singh P, Sharma R, et al.. Probable zoonotic leprosy in the southern United States. N Engl J Med. 2011, 364:1626-33. 10.1056\/NEJMoa1010536","journal-title":"N Engl J Med"},{"key":"ref7","unstructured":"About Leprosy | ILEP Federation. (2023). Accessed. July 05, 2023: https:\/\/ilepfederation.org\/about-leprosy."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.48656","article-title":"Relapse in leprosy","volume":"75","author":"Kaimal S","year":"2009","unstructured":"Kaimal S, Thappa DM. Relapse in leprosy. Indian J Dermatol Venereol Leprol. 2009, 75:126-35. 10.4103\/0378-6323.48656","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.009","article-title":"Leprosy relapse: a retrospective study on epidemiologic, clinical, and therapeutic aspects at a Brazilian referral center","volume":"118","author":"Nascimento AC","year":"2022","unstructured":"Nascimento AC, Dos Santos DF, Antunes DE, et al.. Leprosy relapse: a retrospective study on epidemiologic, clinical, and therapeutic aspects at a Brazilian referral center. Int J Infect Dis. 2022, 118:44-51. 10.1016\/j.ijid.2022.01.009","journal-title":"Int J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.10.138","article-title":"Leprosy: treatment and management of complications","volume":"83","author":"Maymone MB","year":"2020","unstructured":"Maymone MB, Venkatesh S, Laughter M, et al.. Leprosy: treatment and management of complications. J Am Acad Dermatol. 2020, 83:17-30. 10.1016\/j.jaad.2019.10.138","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8909834","article-title":"Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics","volume":"2017","author":"Cantini F","year":"2017","unstructured":"Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D. Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics. Mediators Inflamm. 2017, 2017:8909834. 10.1155\/2017\/8909834","journal-title":"Mediators Inflamm"},{"key":"ref12","article-title":"Risk of tuberculosis reactivation with rituximab therapy","volume":"11","author":"Alkadi A","year":"2017","unstructured":"Alkadi A, Alduaiji N, Alrehaily A. Risk of tuberculosis reactivation with rituximab therapy. Int J Health Sci (Qassim). 2017, 11:41-4.","journal-title":"Int J Health Sci (Qassim)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.03.025","article-title":"Does rituximab increase the incidence of infectious complications? A narrative review","volume":"15","author":"Kelesidis T","year":"2011","unstructured":"Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011, 15:e2-16. 10.1016\/j.ijid.2010.03.025","journal-title":"Int J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101509","article-title":"Opportunistic tropical infections in immunosuppressed patients","volume":"34","author":"Shu Kurizky P","year":"2020","unstructured":"Shu Kurizky P, Dos Santos Neto LL, Barbosa Aires R, Henrique da Mota LM, Martins Gomes C. Opportunistic tropical infections in immunosuppressed patients. Best Pract Res Clin Rheumatol. 2020, 34:101509. 10.1016\/j.berh.2020.101509","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2202672","article-title":"Mantle-cell lymphoma","volume":"386","author":"Armitage JO","year":"2022","unstructured":"Armitage JO, Longo DL. Mantle-cell lymphoma. N Engl J Med. 2022, 386:2495-506. 10.1056\/NEJMra2202672","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18697","article-title":"How I manage mantle cell lymphoma: indolent versus aggressive disease","volume":"201","author":"Wilson MR","year":"2023","unstructured":"Wilson MR, Barrett A, Cheah CY, Eyre TA. How I manage mantle cell lymphoma: indolent versus aggressive disease. Br J Haematol. 2023, 201:185-98. 10.1111\/bjh.18697","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12684","article-title":"The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections","volume":"282","author":"Smedby KE","year":"2017","unstructured":"Smedby KE, Ponzoni M. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J Intern Med. 2017, 282:360-70. 10.1111\/joim.12684","journal-title":"J Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/206466-leprosy-in-a-patient-with-lymphoma-a-challenge-in-the-twenty-first-century","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:18Z","timestamp":1707509538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/206466-leprosy-in-a-patient-with-lymphoma-a-challenge-in-the-twenty-first-century"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.50007","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,5]]}}}